Zeo ScientifiX, Inc. SEC filings ZEOX
Zeo ScientifiX, Inc. has 518 filings in SEC EDGAR's recent list, going back to Sep 4, 2012. Its latest annual report, Form 10-KT, was filed on Oct 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 15, 2026, covering the quarter ended Apr 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Filing | Sep 28, 2026 | Jun 30, 2026 |
| NT 10-Q | Filing | Sep 14, 2026 | Jul 31, 2026 |
| D | Filing | Dec 5, 2025 | — |
| EFFECT | Filing | May 20, 2025 | — |
| CORRESP | Letter to the SEC | May 16, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2025 | — |
| DEL AM | Filing | Mar 27, 2025 | — |
| D | Filing | Jul 16, 2024 | — |
| PRER14C | Filing | Oct 19, 2023 | — |
| D | Filing | Aug 25, 2023 | — |
| NT 10-Q | Filing | Jun 14, 2023 | Apr 30, 2023 |
| UPLOAD | Letter from the SEC | Feb 22, 2023 | — |
| NT 10-K | Filing | Jan 30, 2023 | Oct 31, 2022 |
| UPLOAD | Letter from the SEC | Jan 20, 2023 | — |
| EFFECT | Filing | Oct 24, 2022 | — |
| CORRESP | Letter to the SEC | Oct 20, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2022 | — |
| EFFECT | Filing | Mar 15, 2022 | — |
| CORRESP | Letter to the SEC | Mar 11, 2022 | — |
| CORRESP | Letter to the SEC | Mar 7, 2022 | — |
| NT 10-K | Filing | Jan 31, 2022 | Oct 31, 2021 |
| UPLOAD | Letter from the SEC | Dec 23, 2021 | — |
| CORRESP | Letter to the SEC | Dec 14, 2021 | — |
| PRER14C | Filing | Oct 4, 2021 | — |
| PRER14C | Filing | Sep 30, 2021 | — |
| D | Filing | Aug 16, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2021 | — |
| NT 10-K | Filing | Jan 29, 2021 | Oct 31, 2020 |
| NT 10-Q | Notice of late filing | Jun 15, 2018 | Apr 30, 2018 |
| NT 10-K | Filing | Jan 29, 2018 | Oct 31, 2017 |
| NT 10-Q | Filing | Sep 14, 2017 | Jul 31, 2017 |
| NT 10-Q | Filing | Jun 15, 2017 | Apr 30, 2017 |
| NT 10-Q | Filing | Mar 20, 2017 | Jan 31, 2017 |
| NT 10-K | Filing | Jan 30, 2017 | Oct 31, 2016 |
| NT 10-Q | Filing | Sep 14, 2016 | Jul 31, 2016 |
| NT 10-Q | Filing | Mar 16, 2016 | Jan 31, 2016 |
| NT 10-K | Filing | Feb 1, 2016 | Oct 31, 2015 |
| NT 10-Q | Filing | Sep 14, 2015 | Jul 31, 2015 |
| D | Filing | Jun 30, 2015 | — |
| NT 10-K | Bespoke nt 10-k 10/31/14 | Jan 28, 2015 | Oct 31, 2014 |
| UPLOAD | Letter from the SEC | Jul 16, 2014 | — |
| CORRESP | Letter to the SEC | Jul 7, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 25, 2014 | — |
| NT 10-Q | Bespoke nt 10-q 04/30/14 | Jun 16, 2014 | Apr 30, 2014 |
| NT 10-K | Mainbody | Jan 28, 2014 | Oct 31, 2013 |
| NT 10-Q | Bespoke nt 10-q 07/31/13 | Sep 16, 2013 | Jul 31, 2013 |
| 8-A12G | Mainbody | Jul 25, 2013 | — |
| NT 10-K | Mainbody | Jan 29, 2013 | Oct 31, 2012 |
| EFFECT | Filing | Nov 13, 2012 | — |
| CORRESP | Letter to the SEC | Nov 7, 2012 | — |
| UPLOAD | Letter from the SEC | Oct 22, 2012 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2012 | — |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZEOX (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Davie, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1557376
- Former names
- Organicell Regenerative Medicine, Inc. (until Jan 29, 2024); Biotech Products Services & Research, Inc. (until Jun 15, 2018); BESPOKE TRICYCLES INC (until Sep 14, 2015)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.